# A Study to Learn How Nusinersen (Spinraza) Affects Participants With Spinal Muscular Atrophy (SMA) Who Took it Before or During Pregnancy And About The Health of Their Babies

> **NCT05789758** · — · RECRUITING · sponsor: **Biogen** · enrollment: 20 (estimated)

## Conditions studied

- Muscular Atrophy, Spinal

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT05789758
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-15
- **Primary completion:** 2032-10-31
- **Final completion:** 2033-10-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05789758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05789758, "A Study to Learn How Nusinersen (Spinraza) Affects Participants With Spinal Muscular Atrophy (SMA) Who Took it Before or During Pregnancy And About The Health of Their Babies". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT05789758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*